Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy
Background
The occurrence of chronic inflammation resulting from infection with human papillomaviruses is an important factor in the development of cervical cancer (CC); thus, deciphering the crosstalk between the tumor microenvironment and innate imm…